Is Haemoglobin A1c a step forward in the diagnosis of diabetes?

This article discusses the pros and cons of utilizing haemoglobin A1c for the diagnosis of diabetes as recommended by the recent consensus statement from the ADA,EASD and IDF.The authors acknowledge the benifits of the shift to haemoglobin A1c while highlighting the potential pittfalls of this strategy related to haemoglobinpathies, conditions of shortend red cell survival and standardization.http://www.bmj.com/cgi/content/extract/339/nov10_1/b4432

Harmonizing the Metabolic Syndrome

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. Circulation 2009;120(16):1640-5.

 

This latest joint statement from the International Diabetes Federation (IDF), the National Heart, Lung, and Blood Institute (NHLBI), the World Heart Federation, the International Atherosclerosis Society, and the American Heart Association (AHA) attempts to tighten up the definition of the metabolic syndrome.